Breast augmentation is the most frequent aesthetic surgery operation in the world. In most cases it highly rises up patients self-confidence. Even its not really a difficult surgical procedure, it can bring many postoperative complications which can cause frustration for both patient and surgeon. Keywords: breast augmentation, breast implant, complication.

• Klíčová slova
• breast augmentation, breast implant, complication,
• MeSH
• estetika MeSH
• implantace prsní náhrady * MeSH
• lidé MeSH
• mamoplastika * MeSH
• pooperační komplikace MeSH
• prsní implantáty * MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH

The reconstruction of the anterior cruciate ligament is of great importance to normal knee joint kinematics. Only the isometric reconstruction of the ACL with autologous tissue is viable for longterm function. For early functional follow-up treatment of ACL reconstruction with suture repair, however, augmentation with synthetic ligaments is necessary in order to prevent secondary instability. Anatomic, specimen-experimental, and materials technique were performed to demonstrate the importance of augmentation for ACL reconstruction. The postoperative clinical follow-up examination with LAD augmented ACL reconstructions showed very good results with regard to stability, mobility and function in more than 90 percent of the cases. Key words: anterior cruciate ligament, reconstruction, instability, augmentation.

• Publikační typ
• anglický abstrakt MeSH
• časopisecké články MeSH

The issue of bone volume loss is playing an increasing role in bone tissue engineering. Research has focused on studying the preparation and use of different types of human or xenogenic materials and their osteogenic properties. An alternative source for this purpose could be autologous extracted teeth. The simple preparation protocol, minimal immune response, and rapid organizing of the newly formed bone with optimal mechanical properties predispose autologous hard teeth tissues (HTTs) as a promising material suitable in the indication of augmentation of maxillary and mandible defects, comparable to other high-end augmentation materials. The aim of this study was to experimentally evaluate the osteogenic potential of ground native autologous HTTs prepared by different demineralization procedures, aimed at potentiating the osteoinductive and osteoconductive properties of their organic components. The results indicate that the most effective preparation process for HTT stimulation is the application of Cleanser for 10 min followed by exposure to 0.6 N HCl for 5 min with a wash in phosphate-buffered saline solution.

• Klíčová slova
• bone augmentation materials, demineralization, natural autologous hard teeth tissues, osteogenic activity,
• Publikační typ
• časopisecké články MeSH

This study was undertaken to compare implant survival after one- or two-stage sinus augmentation. Ninety-two maxillary sinuses in 77 patients were augmented with deproteinized bovine bone (Bio-Oss). These sinuses were sub-divided into two groups: Group 1 (n = 49) was operated on with a one-stage procedure, and Group 2 (n = 43) with a two-stage operation. A hundred and eighty-five implants were inserted in these augmented sinuses. Clinical and radiographical evaluations were performed and recorded according to certain criteria. The follow-up period was ranging from 16 to 44 months. Out of the implants inserted using the one-stage procedure, all survived. Two implants failed in the two-stage procedure group (98.91% implant survival). This study showed that no statistically significance was observed between the two surgical techniques (P < 0.05). Therefore, the authors concluded the type of surgical procedure (one- or two-stage) has no effect on implant survival.

• MeSH
• augmentace alveolárního výběžku MeSH
• endoseální implantace zubů MeSH
• kostní náhrady aplikace a dávkování   MeSH
• lidé MeSH
• minerály aplikace a dávkování   MeSH
• neúspěšná terapie MeSH
• sinus maxillaris chirurgie   MeSH
• Check Tag
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• srovnávací studie MeSH
• Názvy látek
• Bio-Oss MeSH Prohlížeč
• kostní náhrady MeSH
• minerály MeSH

Breast augmentation with implants is one of the most commonly performed plastic surgery procedures. The goal of the operation is to increase the size, shape or fullness of the breast. It is accomplished by placing silicone, saline or alternative composite breast implants under the chest muscles, fascia or the mammary gland. This type of operation is no exception with regards to concerning the occurrence of complications. The most common early complications include an infectious process, a seroma, and a hematoma, and the late ones include capsular contracture, reoperation, implant removal, breast asymmetry, and a rupture or deflation of the implant. The authors present a case of subacute arterial bleeding after simultaneous mastopexy and breast augmentation with silicone implants in a 27-year-old woman. The patient complained of worsening swelling and pain in the right breast. The patient denied having had any traumas. Ultrasonography indicated 2.5 cm heterogeneous fluid collections around the implant. Therefore, revision surgery was performed, and a hematoma of 650 mL was removed. Hemorrhage from a branch of the internal mammary artery was found. After the revision, the implant was returned to the lodge. The postoperative period was uneventful. This case report presents a description of a subacute hematoma after simultaneous mastopexy and breast augmentation with silicone implants, which is an extremely rare complication in aesthetic surgery.

• Klíčová slova
• Breast augmentation, aesthetic breast., complication, hematoma,
• MeSH
• dospělí MeSH
• implantace prsní náhrady * MeSH
• lidé MeSH
• mamoplastika * metody   MeSH
• pooperační komplikace MeSH
• prsní implantáty * MeSH
• reoperace MeSH
• retrospektivní studie MeSH
• serom MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• kazuistiky MeSH

Subantral augmentation (sinus lift) is used to increase alveolar bone mass of lateral maxilla in order to insert dental implants. In addition to the autogenous bone several foreign materials can be used for augmentation and they can replace the autogenous bone to some extent. Histological findings in specimens taken nine months after augmentation with the autogenous bone, deproteinised bovine bone (Bio-Oss) and beta-tricalcium phosphate (Cerasorb) are presented. In all cases a new bone formation around the augmentation material was seen. The new bone was deposited predominantly on its surface. In cases with Cerasorb the new bone formation was observed within the porous granules, too. From the obtained results it can be concluded, that the main osteogenetic mechanism in the examined augmentation materials was osteoconduction. The biocompatibility of the used augmentation materials was evidenced by an absence of giant cell granulomatous reaction and of marked inflammatory infiltrate.

• MeSH
• augmentace alveolárního výběžku * MeSH
• biokompatibilní materiály MeSH
• dospělí MeSH
• fosforečnany vápenaté MeSH
• implantace zubů MeSH
• kostní náhrady * MeSH
• lidé středního věku MeSH
• lidé MeSH
• minerály MeSH
• osteogeneze * MeSH
• processus alveolaris patologie   MeSH
• senioři MeSH
• sinus maxillaris * MeSH
• transplantace kostí * MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• anglický abstrakt MeSH
• časopisecké články MeSH
• Názvy látek
• beta-tricalcium phosphate MeSH Prohlížeč
• Bio-Oss MeSH Prohlížeč
• biokompatibilní materiály MeSH
• fosforečnany vápenaté MeSH
• kostní náhrady * MeSH
• minerály MeSH

Mycobacterium thermoresistibile (MT) infections are extremely rare in humans. This nontuberculous mycobacterial species has been associated with lung, skin, and soft tissue infections. We present the case of a 37-year-old woman who underwent augmentation mammoplasty at another institution and developed a persistent MT infection in the right breast, requiring removal of the infected breast implant, antibiotic therapy and multiple surgical treatments. After three months of targeted antimicrobial therapy, we planned a secondary augmentation mammoplasty, starting the procedure in the non-infected breast with removal of the prepectoral implant and creation of a subpectoral pocket using a dual plane technique. Subsequently, in the affected breast we performed a placement of a subpectoral implant with the same technique and lipofilling. Finally, an inverted T-shaped resection of skin tissue was required on the left breast. After 12 months of follow-up, we obtained an acceptable aesthetic result and reported no recurrence of infection. This is the first case of MT infection in Latin America and of successful secondary augmentation mammoplasty after MT infection.

• Klíčová slova
• atypical mycobacteria, breast augmentation, breast deformity, nontuberculous mycobacteria, surgical site infections,
• MeSH
• atypické mykobakteriální infekce * chirurgie   MeSH
• dospělí MeSH
• implantace prsní náhrady metody   MeSH
• infekce spojené s protézou chirurgie   mikrobiologie   etiologie   MeSH
• lidé MeSH
• mamoplastika * metody   MeSH
• prsní implantáty * MeSH
• reoperace MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• kazuistiky MeSH

OF RECOMMENDATIONS1. Oxytocin for induction or augmentation of labor should not be started when there is a previous scar on the body of the uterus (such as previous classical cesarean section, uterine perforation or myomectomy when uterine cavity is reached) or in any other condition where labor or vaginal delivery are contraindicated. (Moderate quality evidence +++-; Strong recommendation).2. Oxytocin should not be started before at least 1 h has elapsed since amniotomy, 6 h since the use of dinoprostone (30 min if vaginal insert) and 4 h since the use of misoprostol (Low quality evidence ++- -; Moderate recommendation).3. Cardiotocography (CTG) should be performed and a normal pattern without tachysystole should be documented for at least 30 min before oxytocin is used. Continuous CTG, with adequate monitoring of both fetal heart rate and uterine contractions, should be maintained for as long as oxytocin is used, and thereafter until delivery (Low ++- - to moderate +++- quality evidence; Strong recommendation).4. For labor induction, at least 1-h should be allowed after amniotomy before oxytocin infusion is started, to evaluate whether adequate uterine contractility has meanwhile ensued. For augmentation of labor, if the membranes are intact and there are conditions for a safe amniotomy, the latter should be considered before oxytocin is started (Very low quality evidence +- --; Weak recommendation).5. Oxytocin should be administered intravenously using the following regimen: 5 IU oxytocin diluted in 500 mL of 0.9% normal saline (NaCl) (each mL contains 10 mIU of oxytocin), in an infusion pump at increasing rates, as shown in Table 1, until a frequency of 3-4 contractions per 10 min is reached, a non-reassuring CTG pattern ensues, or maximum rates are reached (Low quality evidence ++ - -; Strong recommendation). If the frequency of contractions exceeds 5 in 10 min, the infusion rate should be reduced, even if a normal CTG pattern is present. With a non-reassuring CTG pattern, urgent clinical assessment by an obstetrician is indicated, and strong consideration should be given to reducing or stopping the oxytocin infusion. The minimal effective dose of oxytocin should always be used. (Low ++- - to Moderate +++- - quality evidence; Strong recommendation).[Table: see text]6. Use of oxytocin for induction and augmentation of labor should be regularly audited (Low quality evidence ++--; Strong recommendation).

• Klíčová slova
• European guidelines, Oxytocin, labor augmentation, labor induction,
• MeSH
• císařský řez MeSH
• indukovaný porod * MeSH
• lidé MeSH
• misoprostol MeSH
• novorozenec MeSH
• oxytocin terapeutické užití   MeSH
• perinatální péče MeSH
• těhotenství MeSH
• uterotonika * terapeutické užití   MeSH
• Check Tag
• lidé MeSH
• novorozenec MeSH
• těhotenství MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• misoprostol MeSH
• oxytocin MeSH
• uterotonika * MeSH

The objective of this clinical study was to determine the predictability of endosseous implant placed in a maxillary sinus augmented with deproteinized bovine bone (Bio-Oss). A total of 185 implants (109 titanium and 76 hydroxyapatite-coated) were placed in 77 patients representing 92 sinuses either a one- or two-stage surgical technique. A mixture of venous patient's blood and Bio-Oss was used alone within 20 sinuses (Group 1), or in combination with autogenous bone within 72 sinuses (Group 2). Thirty-nine implants were placed in Group 1 and 147 implants were inserted in Group 2. The grafted sinuses were evaluated clinically and radiographically at second stage surgery. According to certain criteria, of the implants placed, only two titanium implants (1.08%) failed with 98.91% implant survival. There was no statistically variable difference for the use of hydroxyapatite-coated or titanium implants. The two failed implants were from Group 2. No clinical benefit has been achieved from the combination with autogenous bone (P<0.05). All the grafted sinuses were sufficient to place dental implants of at least 12 mm length (100% graft success). The results of this short-term study support the hypothesis that Bio-Oss can be a suitable material for sinus augmentation.

• MeSH
• augmentace alveolárního výběžku metody   MeSH
• endoseální implantace zubů * přístrojové vybavení   MeSH
• kostní náhrady aplikace a dávkování   MeSH
• lidé MeSH
• minerály aplikace a dávkování   MeSH
• pooperační komplikace MeSH
• sinus maxillaris chirurgie   MeSH
• transplantace kostí MeSH
• Check Tag
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• Bio-Oss MeSH Prohlížeč
• kostní náhrady MeSH
• minerály MeSH

Simultaneous breast augmentation with mastopexy is growing in popularity. It is a complex procedure that can lead to post-operative complications, patient dissatisfaction, and increased risk of litigation. The aim of this study is to describe an approach for the inverted-T augmentation-mastopexy technique, which limits intraoperative modifications, minimizes errors, and decreases post-operative complications and patient dissatisfaction. The study included 107 patients with Regnault's grade I and II ptosis and severe pseudoptosis. All patients were marked according to our novel technique, Mastopexy Augmentation Made Applicable and Safer (MAMAS), and operated by a single surgeon. All patients underwent simultaneous breast augmentation with Siltex Mentor Round Silicone Gel breast implants and mastopexy. Pre-operatively and post-operatively, patients filled the BREAST-Q. The mean follow-up was 24 months. Hundred and seven women received treatment in this study. Sixteen presented with post-operative complications, eleven in the early stage of recovery, and five in the late stage. There were eight cases of minor wound healing complications, all treated conservatively. Two cases of infection were noted, both were treated with oral antibiotics. One patient experienced post-operative bleeding after 13 days, which required surgical revision. In the late stage of recovery, five cases of implant displacement occurred and required revision surgery. No cases of capsular contracture and seromas were reported. According to Breast-Q, all patients were satisfied. MAMAS surgical technique, focusing on precise pre-operative marking for augmentation-mastopexy, is simple and easily reproducible. The procedure has a low complication rate and high patient satisfaction. It provides predictable and stable results over time.

• Klíčová slova
• Breast augmentation, Breast implant, Breast-Q, Mastopexy,
• Publikační typ
• časopisecké články MeSH